Bing

SEARCH HISTORY

Abbott (NYSE:ABT) today denied reports that it’s prepping a $25 billion ... Abbott is working with banks on a cash-and-stock proffer, the newspaper report, citing people familiar with the situation. A deal between …
MassDevice · 16 hours ago
Absolute Software Corporation (TSX: ABT) is the industry standard in persistent endpoint ... For patent information, visit www.absolute.com/patents. The Toronto Stock Exchange has neither approved nor disapproved of the information contained in this ...
Technology Marketing Corporation · 23 hours ago
Mylan offered to buy Perrigo in April for cash and stock then worth $205 per share ... Abbott Laboratories Inc (ABT.N) and Paulson & Co, had backed Mylan.
Reuters · BySteve Orlofsky andCaroline Humer · 25 minutes ago
Mylan
Absolute Software Corporation (TSX: ABT) is the industry standard in persistent endpoint ... For patent information, visit www.absolute.com/patents. The Toronto Stock Exchange has neither approved nor disapproved of the information contained in this ...
Stockhouse · 8/17/2015
task in 4.1 seconds which makes it 0.2s quicker than the stock model. Consequently, the top speed has been increased from the electronically-limited 155 mph (250 km/h) to 177 mph (285 km/h). As if this major power …
World Car Fans · 8/20/2015
ABT
Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today. Technically, Abbott Laboratories (NYSE: ABT ) stock is trading at half of its 52-week high. But only technically. Abbott Laboratories ...
The Motley Fool · ByBrian Orelli · 4/30/2013
Abbott Laboratories (NYSE:ABT) has poured cold water on a Financial Times report ... Abbott has been talking to banks for several weeks to prepare the ground for a stock plus cash bid. In some respects, joining the …
Proactiveinvestors · 21 hours ago
In addition to ingredients from its own technology, ABT also commercializes technologies/ingredients for partners, for use in novel skin care products. Aqua Bio Technology i listed on the Axess market of the Oslo Stock Exchange. This information is subject ...
GlobeNewswire · 8/19/2015
Any downside moves can also be seen as buying opportunities. (For related reading, see: 4 Tips For Buying Stocks in a Recession.) Dan Moskowitz does not have any positions in ED, BDX, ABT, ADP or CL.
Investopedia · 4/10/2015
NEW YORK (TheStreet) -- Abbott Laboratories price target was increased to $57 from $53 at Leerink. The firm maintained its "market perform" rating on the stock. The firm also raised its 2016 earnings estimates to $2.40 from $2.37. On Wednesday, Abbott ...
Finanzen · 7/23/2015